Cancers, Vol. 15, Pages 5097: Dose Consideration of Lenvatinib & rsquo;s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy

Conclusions: Lenvatinib does not show a dose-dependent anti-cancer effect on HCC. Combined colchicine and lenvatinib can promote the total anti-cancer effects on HCC.

Source: Cancers - October 22, 2023 Category: Cancer & Oncology Authors: Zu-Yau Lin Ming-Lun Yeh Po-Cheng Liang Po-Yao Hsu Chung-Feng Huang Jee-Fu Huang Chia-Yen Dai Ming-Lung Yu Wan-Long Chuang Tags: Article Source Type: research